2025 Global Biologics Safety Testing Market Revenue Opportunities Report
Description
The 2025 Global Biologics Safety Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biologics Safety Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the biologics safety testing market are Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, and Eurofins Scientific. Thermo Fisher Scientific leads with advanced analytical instruments and biosafety cabinets, recently introducing innovative solutions like the Thermo Scientific 1500 Series Class II Biological Safety Cabinet designed for enhanced laboratory protection and usability. Merck KGaA is notable for its extensive biosafety testing services and has invested heavily, opening a €290 million facility in Maryland and developing assays that significantly reduce testing time and cost. Charles River Laboratories has expanded its capabilities by acquiring SAMDI Tech to improve high-throughput screening and biochemical analyses crucial in drug discovery. Eurofins Scientific continues to broaden its sterilization and biosafety testing services portfolio, enhancing its global reach and technological offerings.
These companies dominate through extensive service portfolios covering sterility testing, endotoxin detection, viral clearance, and genetic stability assays essential for regulatory compliance in biologics development. Their active participation in global markets, especially North America and Europe, is supported by growing pharmaceutical R&D investments, stringent regulations, and increasing biologics adoption. Each firm employs strategies such as new product launches, acquisitions, collaborations, and regional expansions to maintain leadership in this rapidly growing sector projected to exceed $10 billion by 2034.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biologics Safety Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the biologics safety testing market are Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, and Eurofins Scientific. Thermo Fisher Scientific leads with advanced analytical instruments and biosafety cabinets, recently introducing innovative solutions like the Thermo Scientific 1500 Series Class II Biological Safety Cabinet designed for enhanced laboratory protection and usability. Merck KGaA is notable for its extensive biosafety testing services and has invested heavily, opening a €290 million facility in Maryland and developing assays that significantly reduce testing time and cost. Charles River Laboratories has expanded its capabilities by acquiring SAMDI Tech to improve high-throughput screening and biochemical analyses crucial in drug discovery. Eurofins Scientific continues to broaden its sterilization and biosafety testing services portfolio, enhancing its global reach and technological offerings.
These companies dominate through extensive service portfolios covering sterility testing, endotoxin detection, viral clearance, and genetic stability assays essential for regulatory compliance in biologics development. Their active participation in global markets, especially North America and Europe, is supported by growing pharmaceutical R&D investments, stringent regulations, and increasing biologics adoption. Each firm employs strategies such as new product launches, acquisitions, collaborations, and regional expansions to maintain leadership in this rapidly growing sector projected to exceed $10 billion by 2034.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
